Methods For Treating Skin Infection By Administering An Il-4R Antagonist - EP3110848

The patent EP3110848 was granted to Regeneron Pharmaceuticals on Feb 14, 2024. The application was originally filed on Feb 26, 2015 under application number EP15710650A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3110848

REGENERON PHARMACEUTICALS
Application Number
EP15710650A
Filing Date
Feb 26, 2015
Status
Granted And Under Opposition
Jan 12, 2024
Grant Date
Feb 14, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMPTON KNOWLESNov 14, 2024D YOUNGADMISSIBLE
LUIGINov 14, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBBNov 13, 2024ENGELHARDADMISSIBLE
DORRIESNov 13, 2024DORRIESADMISSIBLE
DORRIESNov 13, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE
SECERNANov 13, 2024SECERNAADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2012097565
DESCRIPTIONUS2014072583
DESCRIPTIONUS7186809
DESCRIPTIONUS7605237
DESCRIPTIONUS7608693
DESCRIPTIONUS8092804
INTERNATIONAL-SEARCH-REPORTWO2014039461
OPPOSITIONWO2010053751
OPPOSITIONWO2012047954
OPPOSITIONWO2014031610
OPPOSITIONWO2014039461
OTHEREP2892927
OTHERWO2014039461

Non-Patent Literature (NPL) Citations (78) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- BLAUVELT ANDREW ET AL, "No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab", ADVANCES IN THERAPY., US, vol. 40, no. 1, doi:10.1007/s12325-022-02322-y, ISSN 0741-238X, (20221101), pages 367 - 380, URL: https://link.springer.com/article/10.1007/s12325-022-02322-y/fulltext.html, XP093104397
OPPOSITION- A Garriga, "71st ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGY (AAD)", Drugs of the Future, (20130301), pages 275 - 279, XP055566346
OPPOSITION- Anonymous, "CIBINQO (abrocitinib) tablets, for oral use - HIGHLIGHTS OF PRESCRIBING INFORMATION", FDA, (20230201), XP093283555
OPPOSITION- Anonymous, "Dupilumab - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS", EMEA, (20220901), XP093231635
OPPOSITION- Anonymous, "International Nonproprietary Names for Pharmaceutical Substances (INN), List 108", WHO Drug Information, (20120101), vol. 26, no. 4, pages 401 - 471, XP055932074
OPPOSITION- Anonymous, "Ringworm and Fungal Nail Infections Basics", U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), (20240424), U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), URL: https://www.cdc.gov/ringworm/about/index.html#print, XP093238349
OPPOSITION- Bieber Thomas R.M., Thaci Diamant, Graham Neil, Pirozzi Gianluca, Teper Ariel, Ren Haobo, Radin Allen, "Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study", J Allergy Clin Immunol.; AB404 Abstracts, (20140201), XP093238339
OPPOSITION- Boguniewicz, M. ; Leung, D.Y.M., "Recent insights into atopic dermatitis and implications for management of infectious complications", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20100101), vol. 125, no. 1, ISSN 0091-6749, pages 4 - 13, XP026823290
OPPOSITION- Charles Bankhead, "IL-4 Antibody Tames Atopic Dermatitis", Medpage Today, (20130303), pages 1 - 3, Medpage Today, URL: https://www.medpagetodaY.com/meetingcoverage/aad/37636, (20190308), XP055566311
OPPOSITION- D10 - Abstracts of “6th International Investigative Dermatology Meeting” May 8­ 11, 2013 in Edinburgh, Scotland, United Kingdom, J Invest Dermatol. 2013 May;133 Suppl 1:S1-311
OPPOSITION- D13a - PRINTOUT OF THE WEBSITE OF SCIENCEDIRECT SHOWING THAT D13 WAS AVAILABLE ONLINE AS OF JANUARY 23, 2014
OPPOSITION- D13b - orrespondence with the Editors of The Journal of Allergy and Clinical Immunology about publication date of D13
OPPOSITION- D1 - APPLICANTS’ SUBMISSION FILED DURING EXAMINATION PROCEEDINGS ON AUGUST 8, 2019
OPPOSITION- D36 - Beck et al (Supplementary Appendix)
OPPOSITION- D37 - Beck et al (Protocol)
OPPOSITION- D47 - Infection v. Colonization. Multi Drug Resistant Organisms Management in Long Term Care Facilities Workshop Louisiana Office of Public Health Healthcare Associated Infections Program. https://ldh.la.gov/assets/oph/Center-PHCH/Center- CH/infectiousepi/HAI/MDRO2017/handouts/ColonizationvInfection.pdf - 2017; no date to be found on the slides
OPPOSITION- D49 - Thaçi et al (Supplementary Appendix)
OPPOSITION- D50 - CDR Clinical Review Report for Dupixent (Appendix 4). CADTH COMMON DRUG REVIEW, 117-127. June 2020
OPPOSITION- D66 - Regeneron Pharmaceuticals, Inc., SEC Form 8-K dated March 4, 2024, including Exhibit 99.1: Bieber T. et al. Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis:A 12-Week, Randomized, Double-Blind, Placebo Controlled Study ("Bieber et al.")
OPPOSITION- D71 - 2014 AAAI program for late breaking abstracts WayBack Machine print out
OPPOSITION- D73 - JACI List of Issues Archive
OPPOSITION- D81 - Use of Dupilumab for Disseminated Fungal Infection (date?)
OPPOSITION- D9 - Copy of four posters (#1042, #1048, #1049, #1050) presented by Regeneron Pharmaceuticals, Inc. and Sanofi among others at the “6th International Investigative Dermatology Meeting” in Edinburgh, Scotland, United Kingdom, May 8-11, 2013
OPPOSITION- Ference, Last, "Choosing Topical Corticosteroids", AMERICAN FAMILY PHYSICIAN, American Academy of Family Physicians, US, US , (20090101), vol. 79, no. 2, ISSN 0002-838X, pages 135 - 140, XP093283581
OPPOSITION- Mark G Lebwohl, James Q. Del Rosso, William Abramovits, Brian Berman, David E. Cohen, Emma Guttman-Yassky, Anthony J. Mancini, And Lawrence A. Schachner, "Pathways to Managing Atopic Dermatitis: Consensus From the Experts", JOURNAL OF DRUGS IN DERMATOLOGY, STRATEGIC COMMUNICATION IN DERMATOLOGY, NEW YORK, NY, US, US , (20130601), vol. 6, no. 7 Suppl, ISSN 1545-9616, pages S2 - S18, XP055436108
OPPOSITION- Milo Gibaldi, "Chapter 1: Introduction to Pharmacokinetics", Milo Gibaldi, MILO GIBALDI, Biopharmaceutics and Clinical Pharmacokinetics, FOURTH EDITION, Lea & Febinger, (19900101), pages 1 - 13, ISBN 0-8121-1346-2, XP009558949
OPPOSITION- Paris, Tarrytown, "SANOFI AND REGENERON ANNOUNCE PUBLICATION OF POSITIVE PHASE 2A RESULTS OF DUPILUMAB IN ASTHMA IN THE NEW ENGLAND JOURNAL OF MEDICINE", New England Journal of Medicine, (20130521), pages 1 - 3, XP055928700
OPPOSITION- Rehmus Wingfield E., "Cellulitis", MSD MANUAL - PROFESSIONAL VERSION, (20230601), MSD MANUAL - PROFESSIONAL VERSION, URL: https://www.msdmanuals.com/professional/dermatologic-disorders/bacterial-skin-infections/cellulitis, XP093238351
OPPOSITION- "Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis", 71st Annual Meeting of the American Academy of Dermatology, (20130302), pages 1 - 3, XP007922251
OPPOSITION- Stuart Proudfoot, "19. Dosage regimens", Pharmaceuticals: The Science of Dosage Form Administratio. 2nd Ed, (20020101), pages 275 - 288, XP055397036
OPPOSITION- Thomas L. Bosshardt, Vernon J. Henderson, Claude H. Organ Jr., "Necrotizing soft-tissue infections", Thomas L. Bosshardt, Vernon J. Henderson, Claude H. Organ Jr., Rene G. Holzheimer, John A. Mannick, Surgical Treatment - Evidence-Based and Problem-Oriented, W. Zuckschwerdt Verlag, (20010101), pages 656 - 660, ISBN 3-88603-714-2, XP009558948
OPPOSITION- Cohen Yehuda Z., Zhang Xiaojia, Xia Binfeng, Kosloski Matthew P., Kamal Mohamed A., Davis John D., Kanamaluru Vanaja, Xu Christine, "Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe", Clinical Pharmacology in Drug Development, Wiley-Blackwell Publishing Ltd., GB, GB , (20220501), vol. 11, no. 5, doi:10.1002/cpdd.1073, ISSN 2160-763X, pages 675 - 681, XP093235860
OPPOSITION- Lin Y T, Wang C T, Chiang B L, "Role of bacterial pathogens in atopic dermatitis.", CLINICAL REVIEWS IN ALLERGY AND IMMUNOLOGY, HUMANA PRESS, TOTOWA, NJ, US, US , (20071201), vol. 33, no. 3, doi:10.1007/s12016-007-0044-5, ISSN 1080-0549, pages 167 - 177, XP002739302
OPPOSITION- Silverberg Jonathan I., Silverberg Nanette B., "Atopic Dermatitis: Update on Pathogenesis and Comorbidities", Current Dermatology Reports, (20121201), vol. 1, no. 4, doi:10.1007/s13671-012-0021-y, pages 168 - 178, XP093054447
OPPOSITION- Nilsson, E.J. ; Henning, C.G. ; Magnusson, J., "Topical corticosteroids and Staphylococcus aureus in atopic dermatitis", Journal of the American Academy of Dermatology, Mosby, Inc, US, US , (19920701), vol. 27, no. 1, doi:10.1016/0190-9622(92)70151-5, ISSN 0190-9622, pages 29 - 34, XP025613504
OPPOSITION- Theo Rispens, Gestur Vidarsson, "Chapter 9 - Human IgG Subclasses", Antibody Fc: Linking Adaptive and Innate Immunity, Academic Press, (20140101), pages 159 - 177, doi:10.1016/B978-0-12-394802-1.00009-1, ISBN 9780123948021, XP009558950
OPPOSITION- Werfel Thomas, Kapp Alexander, "Atopic dermatitis and allergic contact dermatitis", Allergy, Elsevier , (20120101), pages 263 - 286, doi:10.1016/C2009-0-46113-0, ISBN 978-0-7234-3658-4, XP093235762
OPPOSITION- Giavina-Bianchi Mara, Rizzo Luiz Vicente, Giavina-Bianchi Pedro, "Severe atopic dermatitis: Dupilumab is not just safer, but more efficient", ALLERGOLOGIA ET IMMUNOPATHOLOGIA, GARSI, MADRID,, ES, ES , (20201101), vol. 48, no. 6, doi:10.1016/j.aller.2019.12.005, ISSN 0301-0546, pages 792 - 797, XP093283570
OPPOSITION- Howell, M.D. Boguniewicz, M. Pastore, S. Novak, N. Bieber, T. Girolomoni, G. Leung, D.Y.M., "Mechanism of HBD-3 deficiency in atopic dermatitis", CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20061115), vol. 121, no. 3, doi:10.1016/j.clim.2006.08.008, ISSN 1521-6616, pages 332 - 338, XP005740934
OPPOSITION- Ong Peck Y., Leung Donald Y.M., "The Infectious Aspects of Atopic Dermatitis", IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, SAUNDERS, PHILADELPHIA, US, US , (20100801), vol. 30, no. 3, doi:10.1016/j.iac.2010.05.001, ISSN 0889-8561, pages 309 - 321, XP093238355
OPPOSITION- Spergel J, "Atopic dermatitis and the atopic march", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20031201), vol. 112, no. 6, doi:10.1016/j.jaci.2003.09.033, ISSN 0091-6749, pages S118 - S127, XP093238364
OPPOSITION- for the European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group Akdis, C.A. Akdis, M. Bieber, T. Bindslev-Jensen, C. Boguniewicz, M. Eigenmann, P. Hamid, Q. Kapp, A. Leung, D.Y.M. Lipozencic, J. Lug, "Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20060701), vol. 118, no. 1, doi:10.1016/j.jaci.2006.03.045, ISSN 0091-6749, pages 152 - 169, XP005523634
OPPOSITION- Boguniewicz, M. Schmid-Grendelmeier, P. Leung, D.Y.M., "Atopic dermatitis", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20060701), vol. 118, no. 1, doi:10.1016/j.jaci.2006.04.044, ISSN 0091-6749, pages 40 - 43, XP005523619
OPPOSITION- Jensen, J.M. ; Pfeiffer, S. ; Witt, M. ; Brautigam, M. ; Neumann, C. ; Weichenthal, M. ; Schwarz, T. ; Folster-Holst, R. ; Proksch, E., "Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20090501), vol. 123, no. 5, doi:10.1016/j.jaci.2009.03.032, ISSN 0091-6749, pages 1124 - 1133, XP026083375
OPPOSITION- Emma Guttman-Yassky; Kristine E. Nograles; James G. Krueger;, "Contrasting pathogenesis of atopic dermatitis and psoriasisPart I: Clinical and pathologic concepts", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20110105), vol. 127, no. 5, doi:10.1016/j.jaci.2011.01.053, ISSN 0091-6749, pages 1110 - 1118, XP028198096
OPPOSITION- Alexander A. Navarini; Lars E. French; Gnther F.L. Hofbauer;, "Interrupting IL-6receptor signaling improves atopic dermatitis but associates with bacterial superinfection", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , vol. 128, no. 5, doi:10.1016/j.jaci.2011.09.009, ISSN 0091-6749, pages 1128 - 1130, XP028330236
OPPOSITION- Tkachenko Eugene; Rawson Renee; La Elizabeth; Doherty Taylor A.; Baum Rachel; Cavagnero Kellen; Miyanohara Atsushi; Dohil Ranjan; Kurten Richard C.; Aceves Seema S., "Rigid substrate induces esophageal smooth muscle hypertrophy and eosinophilic esophagitis fibrotic gene expression", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20151102), vol. 137, no. 4, doi:10.1016/j.jaci.2015.09.020, ISSN 0091-6749, page 1270, XP029494556
OPPOSITION- He Helen; Del Duca Ester; Diaz Aisleen; Kim Hyun Je; Gay-Mimbrera Jesús; Zhang Ning; Wu Jianni; Beaziz Jessica; Estrada Yeriel; Krueger James G.; Pavel Ana B.; Ruano Juan; Guttman-Yassky Emma, "Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20201001), vol. 147, no. 4, doi:10.1016/j.jaci.2020.08.041, ISSN 0091-6749, pages 1369 - 1380, XP086529008
OPPOSITION- Simpson Eric L., Schlievert Patrick M., Yoshida Takeshi, Lussier Stephanie, Boguniewicz Mark, Hata Tissa, Fuxench Zelma, De Benedetto Anna, Ong Peck Y., Ko Justin, Calatroni Agustin, Rudman Spergel Amanda K., Plaut Marshall, Quataert Sally A., Kilgore Samuel H., Peterson Liam, Gill Ann L., David Gloria, Mosmann Tim, Gill Steven R., Leung Donald Y.M., Beck Lisa A., "Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20231101), vol. 152, no. 5, doi:10.1016/j.jaci.2023.05.026, ISSN 0091-6749, pages 1179 - 1195, XP093283563
OPPOSITION- Traidl Stephan; Harries Leonard; Kienlin Petra; Begemann Gabriele; Roesner Lennart M.; Werfel Thomas, "Dupilumab strengthens herpes simplex virus type 1-specific immune responses in atopic dermatitis", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20230901), vol. 152, no. 6, doi:10.1016/j.jaci.2023.08.024, ISSN 0091-6749, page 1460, XP087436552
OPPOSITION- Arkwright Peter D., Motala Cassim, Subramanian Hamsa, Spergel Jonathan, Schneider Lynda C., Wollenberg Andreas, "Management of Difficult-to-Treat Atopic Dermatitis", The journal of allergy and clinical immunology : an official journal of AAAAI, American Academy of Allergy Asthma & Immunology, Elsevier BV, NL, NL , (20130301), vol. 1, no. 2, doi:10.1016/j.jaip.2012.09.002, ISSN 2213-2198, pages 142 - 151, XP093283582
OPPOSITION- Furue Masutaka, Matsumoto Tsuyoshi, Yamamoto Tetsuo, Takeuchi Satoshi, Esaki Hitokazu, Chiba Takahito, Yamaguchi Hideyo, "Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis", Journal of Dermatological Science, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20120401), vol. 66, no. 1, doi:10.1016/j.jdermsci.2012.01.011, ISSN 0923-1811, pages 60 - 63, XP093238366
OPPOSITION- Thaçi Diamant; Simpson Eric L; Beck Lisa A; Bieber Thomas; Blauvelt Andrew; Papp Kim; Soong Weily; Worm Margitta; Szepietowski Jacek C; Sofen Howard; Kawashima Makoto; Wu Richard; Weinstein Steven P; Graham Neil M H; Pirozzi Gianluca; Teper Ariel; Sutherland E Rand; Mastey Vera; Stahl Neil; Yancopoulos George D; Ardeleanu Marius, "Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20151008), vol. 387, no. 10013, doi:10.1016/S0140-6736(15)00388-8, ISSN 0140-6736, pages 40 - 52, XP029378549
OPPOSITION- Eisenstein M, "Something new under the skin", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20110101), vol. 29, no. 2, doi:10.1038/nbt.1768, ISSN 1087-0156, pages 107 - 109, XP009152843
OPPOSITION- Pournaras Constance C., Jann Lübbe, Jean-Hilaire Surat, "Staphylococcal Colonization in Atopic Dermatitis Treatment with Topical Tacrolimus (Fk506) ", THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, (20010301), vol. 116, no. 3, doi:10.1046/j.1523-1747.2001.12799.x, pages 480 - 481, XP093283580
OPPOSITION- Paintaud Gilles, "Pharmacocinétique des anticorps monoclonaux", M/S MEDECINE SCIENCES., SOCIETE DES PERIODIQUES FLAMMARION, PARIS,, FR, FR , (20091201), vol. 25, no. 12, doi:10.1051/medsci/200925121057, ISSN 0767-0974, pages 1057 - 1062, XP093238361
OPPOSITION- ONG P Y, ET AL., "ENDOGENOUS ANTIMICROBIAL PEPTIDES AND SKIN INFECTIONS IN ATOPIC DERMATITIS", The New England journal of medicine, Massachusetts Medical Society, US, US , (20021010), vol. 347, no. 15, doi:10.1056/NEJMoa021481, ISSN 0028-4793, pages 1151 - 1160, XP008028910
OPPOSITION- Beck Lisa A; Thaçi Diamant; Hamilton Jennifer D; Graham Neil M; Bieber Thomas; Rocklin Ross; Ming Jeffrey E; Ren Haobo; Kao Richard; Simpson Eric; Ardeleanu Marius; Weinstein Steven P; Pirozzi Gianluca; Guttman-Yassky Emma; Suárez-Fariñas Mayte; Hager Melissa D; Stahl Neil; Yancopoulos George D; Radin Allen R, "Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.", New England Journal of Medicine, The - NEJM, Massachusetts Medical Society, US, US , (20140710), vol. 371, no. 2, doi:10.1056/NEJMoa1314768, ISSN 1533-4406, pages 130 - 139, XP009180485
OPPOSITION- Thomas Bieber, "Atopic Dermatitis", The New England Journal of Medicine, (20080403), vol. 358, no. 14, doi:10.1056/NEJMra074081, pages 1483 - 1494, XP009194018
OPPOSITION- Remitz Anita, Kyllönen Hannele, Granlund Håkan, Reitamo Sakari, "Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions", Journal of Allergy and Clinical Immunology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20010101), vol. 107, no. 1, doi:10.1067/mai.2001.112131, ISSN 0091-6749, pages 196 - 197, XP093238360
OPPOSITION- Wollenberg Andreas, Wetzel Stefanie, Burgdorf Walter H C, Haas Jürgen, "Viral infections in atopic dermatitis: Pathogenic aspects and clinical management", J Allergy Clin Immunol, (20031001), vol. 112, no. 4, doi:10.1067/mai.2003.1775, pages 667 - 674, XP093238357
OPPOSITION- Hartmann Jan, Moitinho‐silva Lucas, Sander Nicole, Harder Inken, Häsler Robert, Rodriguez Elke, Haufe Eva, Kleinheinz Andreas, Abraham Susanne, Heratizadeh Annice, Weisshaar Elke, Schäkel Knut, Handrick Christiane, Augustin Matthias, Wollenberg Andreas, Staubach‐renz Petra, Ertner Konstantin, Sticherling Michael, Schwarz Beate, Quist Sven, Wiemers Franca, Schenck Florian, Wildberger Julia, Tittmann Lukas, Lieb Wolfgang, Schmitt Jochen, Werfel Thomas, Weidinger Stephan, "Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate‐to‐severe atopic dermatitis", ALLERGY, Wiley-Blackwell Publishing Ltd., United Kingdom, United Kingdom , (20230801), vol. 78, no. 8, doi:10.1111/all.15742, ISSN 0105-4538, pages 2290 - 2300, XP093283567
OPPOSITION- Ring J., Alomar A., Bieber T., Deleuran M., Fink‐wagner A., Gelmetti C., Gieler U., Lipozencic J., Luger T., Oranje A.P., Schäfer T., Schwennesen T., Seidenari S., Simon D., Ständer S., Stingl G., Szalai S., Szepietowski J.C., Taïeb A., Werfel T., Wollenberg A., Darsow U., "Guidelines for treatment of atopic eczema (atopic dermatitis) Part I", JEADV , The Journal of the European Academy of Dermatology and Venereology, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM., NL, NL , (20120101), vol. 26, no. 8, doi:10.1111/j.1468-3083.2012.04635.x, ISSN 0926-9959, pages 1045 - 1060, XP093235834
OPPOSITION- Mark Boguniewicz, Et Al., "Atopic Dermatitis: A Disease of Altered Skin Barrier and Immune Dysregulation", Immunological Reviews, (20110731), vol. 242, no. 1, doi:10.1111/j.1600-065X.2011.01027.x, pages 233 - 246, XP055581377
OPPOSITION- Kei-ichi Yamanaka ; Hitoshi Mizutani, "The Role of Cytokines/Chemokines in the Pathogenesis of Atopic Dermatitis", Kei-ichi Yamanaka ; Hitoshi Mizutani, T. Shiohara, Pathogenesis and management of atopic dermatitis, Karger, (20110101), pages 80 - 92, doi:10.1159/000323299, ISBN 978-3-8055-9686-2, XP009558947
OPPOSITION- Ong Peck Y, "Editorial update on emerging treatments of atopic dermatitis", Expert opinion on emerging drugs England, Informa Healthcare, UK, UK , (20120601), vol. 17, no. 2, doi:10.1517/14728214.2012.668884, ISSN 1744-7623, pages 129 - 133, XP009171977
OPPOSITION- Petry V, Bessa G R, Poziomczyck C S, Oliveira C F, Weber M B, Bonamigo R R, d'Azevedo P A, "Bacterial skin colonization and infections in patients with atopic dermatitis.", ANAIS BRASILEIROS DE DERMATOLOGIA, ECN-ED. CIENTIFICA NACIONAL, RIO DE JANEIRO, BR, BR , (20120901), vol. 87, no. 5, doi:10.1590/S0365-05962012000500010, ISSN 0365-0596, pages 729 - 734, XP002739301
OPPOSITION- Chong Albert C, Visitsunthorn Kittipos, Ong Peck Y, "Genetic/Environmental Contributions and Immune Dysregulation in Children with Atopic Dermatitis", Journal of Asthma and Allergy, Dove Medical Press, Volume 15, doi:10.2147/JAA.S293900, ISSN 1178-6965, pages 1681 - 1700, XP093238365
OPPOSITION- Diane R. Mould, Bruce Green, "Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies", BIODRUGS, Adis International Ltd., NZ, NZ , (20100201), vol. 24, no. 1, doi:10.2165/11530560-000000000-00000, ISSN 1173-8804, pages 23 - 39, XP009514743
OPPOSITION- Bai Shuang; Jorga Karin; Xin Yan; Jin Denise; Zheng Yanan; Damico-Beyer Lisa A; Gupta Manish; Tang Meina; Allison David E; Lu Dan; Zhang Yi; Joshi Amita; Dresser Mark J, "A Guide to Rational Dosing of Monoclonal Antibodies", CLINICAL PHARMACOKINETICS., ADIS INTERNATIONAL LTD., AUCKLAND, NZ, NZ , (20120101), vol. 51, no. 2, doi:10.2165/11596370-000000000-00000, ISSN 0312-5963, pages 119 - 135, XP009184175
OPPOSITION- Donald Y.M. Leung, "New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation", ALLERGOLOGY INTERNATIONAL, Japanese Society of Allergology, JP, JP , (20130101), vol. 62, no. 2, doi:10.2332/allergolint.13-RAI-0564, ISSN 1323-8930, pages 151 - 161, XP055520366
OPPOSITION- Biedermann T., "Dissecting the role of infections in atopic dermatitis", ACTA DERMATO-VENEREOLOGICA., Taylor & Francis Ltd., United Kingdom, United Kingdom , vol. 86, no. 2, doi:10.2340/00015555-0047, ISSN 0001-5555, pages 99 - 109, XP093238332
OPPOSITION- Ogonowska Patrycja, Gilaberte Yolanda, Barańska-Rybak Wioletta, Nakonieczna Joanna, "Colonization With Staphylococcus aureus in Atopic Dermatitis Patients: Attempts to Reveal the Unknown", Frontiers in Microbiology, Frontiers Media, Lausanne, Lausanne , vol. 11, doi:10.3389/fmicb.2020.567090, ISSN 1664-302X, XP093238363
OPPOSITION- Umemoto Naoka, Kakurai Maki, Matsumoto Takanao, Mizuno Kenta, Cho Otomi, Sugita Takashi, Demitsu Toshio, "Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis", Microorganisms, MDPI AG, Switzerland, Switzerland, vol. 12, no. 1, doi:10.3390/microorganisms12010224, ISSN 2076-2607, page 224, XP093283576
OPPOSITION- Olesen Caroline Meyer, Ingham Anna Cäcilia, Thomsen Simon Francis, Clausen Maja-Lisa, Andersen Paal Skytt, Edslev Sofie Marie, Yüksel Yasemin Topal, Guttman-Yassky Emma, Agner Tove, "Changes in Skin and Nasal Microbiome and Staphylococcal Species Following Treatment of Atopic Dermatitis with Dupilumab", Microorganisms, MDPI AG, Switzerland, Switzerland, vol. 9, no. 7, doi:10.3390/microorganisms9071487, ISSN 2076-2607, page 1487, XP093283572
OPPOSITION- Bury Jordan, Zirwas Matthew, "Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade", JOURNAL OF DRUGS IN DERMATOLOGY, STRATEGIC COMMUNICATION IN DERMATOLOGY, NEW YORK, NY, US, US , (20231001), vol. 22, no. 10, doi:10.36849/JDD.7249, ISSN 1545-9616, pages 1007 - 1008, XP093283561
OPPOSITION- Eric B. Brandt, "Th2 Cytokines and Atopic Dermatitis", Journal of Clinical & Cellular Immunology, (20110101), vol. 02, no. 03, doi:10.4172/2155-9899.1000110, pages 1 - 13, XP055386816
OPPOSITION- Bieber Thomas, "Atopic Dermatitis", ANNALS OF DERMATOLOGY, KOREAN DERMATOLOGICAL ASSOCIATION, SEOUL, KR, KR , (20100101), vol. 22, no. 2, doi:10.5021/ad.2010.22.2.125, ISSN 1013-9087, page 125, XP093238354

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents